NIAID Banner Logo Image


1. 60069 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Hiv reverse transcriptase inhibitors

Saggar, Sandeep A, Sisko, John T, Tucker, Thomas J, Tynebor, Robert M, Su, Dai-Shi, and Anthony, Neville J

PATENT: US 2007021442 ISSUE DATE: 20070125

APPLICATION: 2006-29133 PP: 72pp.


2. 60070 HIV-LS-367; PUBMED-HIV-2/5/2007

A Mutation in Alpha Helix 3 of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A-Resistant and Dependent: Rescue by a Second-Site Substitution in a Distal Region of CA

Yang, R and Aiken, C

J Virol 2007.


3. 60071 HIV-LS-367; PUBMED-HIV-2/5/2007

Simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic studies

Gu, R, Dou, G, Wang, J, Dong, J, and Meng, Z

J Chromatogr B Analyt Technol Biomed Life Sci 2007.


4. 60072 HIV-LS-367; PUBMED-HIV-2/5/2007

Safety and Pharmacokinetics of Brecanavir, a Novel HIV-1 Protease Inhibitor, Following Repeat Administration with and without Ritonavir in Healthy Adult Subjects

Reddy, SY, Ford, SL, Anderson, MT, Murray, SC, Ng-Cashin, J, and Johnson, MA

Antimicrob Agents Chemother 2007.


5. 60073 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Preparation of aryl phosphate derivatives of d4T having activity against resistant HIV strains

Uckun, Fatih M

PATENT: US 2007015733 ISSUE DATE: 20070118

APPLICATION: 2006-27757 PP: 42pp., Cont.-in-part of U.S. Ser. No. 275,102.

ASSIGNEE: (Parker Hughes Institute, USA

6. 60074 HIV-LS-367; PUBMED-HIV-2/5/2007

HIV-1 integration is inhibited by stimulation of the VPAC2 neuroendocrine receptor

Bokaei, PB, Ma, XZ, Sakac, D, and Branch, DR

Virology 2007.


7. 60075 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Alkenyldiarylmethanes, fused analogs and syntheses thereof

Cushman, Mark S and Deng, Bo-Liang

PATENT: WO 2007005531 ISSUE DATE: 20070111

APPLICATION: 2006 PP: 72pp.

ASSIGNEE: (Purdue Research Foundation, USA

8. 60076 HIV-LS-367; PUBMED-HIV-2/5/2007

Inhibition of HIV-1 Infection of Human CD4+ T Cells by Microbial HSP70 and the Peptide Epitope 407-426

Babaahmady, K, Oehlmann, W, Singh, M, and Lehner, T

J Virol 2007.


9. 60077 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

Balzarini, Jan, Van Herrewege, Yven, Vermeire, Kurt, Vanham, Guido, and Schols, Dominique

Molecular Pharmacology 2007. 71(1): 3-11

10. 60078 HIV-LS-367; PUBMED-HIV-2/5/2007

Broad-spectrum anti-HIV Potential of a Peptide HIV-1 Entry Inhibitor

Cocklin, S, Gopi, H, Querido, B, Nimmagadda, M, Kuriakose, S, Cicala, C, Ajith, S, Baxter, S, Arthos, J, Martin-Garcia, J, and Chaiken, IM

J Virol 2007.


11. 60079 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Oxazolidinecarboxamides as HIV-1 protease inhibitors, and methods of making and using them

Rana, Tariq M, Ali, Akbar, Cao, Hong, Sai, Kiran Kumar Reddy Ga, and Anjum, Saima Ghafoor

PATENT: WO 2007002173 ISSUE DATE: 20070104

APPLICATION: 2006 PP: 194pp., which which

ASSIGNEE: (University of Massachusetts, USA

12. 60080 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Use of modified U1 snRNAs to inhibit HIV-1 replication

Sajic R, Lee K, Asai K, Sakac D, Branch D R, Upton C, and Cochrane A

Nucleic Acids Res 2007. 35(1): 247-55.

13. 60081 HIV-LS-367; PUBMED-HIV-2/5/2007

3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase

Dharmasena, S, Pongracz, Z, Arnold, E, Sarafianos, SG, and Parniak, MA

Biochemistry 2007. 46(3): 828-36


14. 60082 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2

Kim Jae-Ouk, Chakrabarti Bimal K, Guha-Niyogi Anuradha, Louder Mark K, Mascola John R, Ganesh Lakshmanan, and Nabel Gary J

J Virol 2007. 81(3): 1444-50.

15. 60083 HIV-LS-367; PUBMED-HIV-2/5/2007

Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide

Holguin, A, Faudon, JL, Labernardiere, JL, and Soriano, V

J Clin Virol 2007. 38(2): 176-80


16. 60084 HIV-LS-367; PUBMED-HIV-2/5/2007

Plasma adenosine deaminase activity among HIV1 Clade C seropositives: Relation to CD4 T cell population and antiretroviral therapy

Chittiprol, S, Satishchandra, P, Bhimasenarao, RS, Rangaswamy, GR, Sureshbabu, SV, Subbakrishna, DK, Satish, KS, Desai, A, Ravi, V, and Shetty, KT

Clin Chim Acta 2007. 377(1-2): 133-137


17. 60085 HIV-LS-367; SCIFINDER-HIV-1/29/2007

Preparation of phosphono-pent-2-en-1-yl nucleosides and analogs as antiviral and antitumor agents

Hostetler, Karl Y, Beadle, James R, and Choo, Hyunah

PATENT: WO 2006137953 ISSUE DATE: 20061228

APPLICATION: 2006 PP: 67pp.

ASSIGNEE: (The Regents of the Univerisity of California, USA

18. 60086 HIV-LS-367; WOS-HIV-1/28/2007

Design of anti-HIV Ligands by means of minimal topological difference (MTD) method

Duda-Seiman, C, Duda-Seiman, D, Dragos, D, Medeleanu, M, Careja, V, Putz, MV, Lacrama, AM, Chiriac, A, Nutiu, R, and Ciubotariu, D



19. 60087 HIV-LS-367; WOS-HIV-1/28/2007

Virostatics: A new class of anti-HIV drugs

Lori, F, Foli, A, Kelly, LM, and Lisziewicz, J

CURRENT MEDICINAL CHEMISTRY 2007. 14(2): 233-241, 9


20. 60088 HIV-LS-367; WOS-HIV-2/4/2007

Hyperbranched molecular structures with potential antiviral activity: Derivatives of 5,6-dihydroxyindole-2-carboxylic acid

Sechi, M, Casu, F, Campesi, I, Fiori, S, and Mariani, A

MOLECULES 2006. 11(12): 968-977, 10


21. 60089 HIV-LS-367; WOS-HIV-2/4/2007

Syntheses and anti-AIDS activities of polyrotaxane-3 '-azido-3 '-deoxythymidine conjugates

Chung, I, Ha, CS, Lee, JK, Lee, CK, and Xie, D

MACROMOLECULAR RESEARCH 2006. 14(6): 668-672, 5


22. 60090 HIV-LS-367; WOS-HIV-2/4/2007

Synthesis of 2,3,4,7-tetrahydro-1H-azepines as privileged ligand scaffolds for the design of aspartic protease inhibitors via a ring-closing metathesis approach

Brass, S, Chan, NS, Gerlach, C, Luksch, T, Bottcher, J, and Diederich, WE

JOURNAL OF ORGANOMETALLIC CHEMISTRY 2006. 691(24-25): 5406-5422, 17


23. 60091 HIV-LS-367; WOS-HIV-2/4/2007

Development of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

Tamamura, H, Tsutsumi, H, Masuno, H, and Fujii, N

CURRENT MEDICINAL CHEMISTRY 2007. 14(1): 93-102, 10


24. 60092 HIV-LS-367; WOS-HIV-2/4/2007

Screening and selecting for optimized antiretroviral drugs: rising to the challenge of drug resistance

de Bethune, MP and Hertogs, K

CURRENT MEDICAL RESEARCH AND OPINION 2006. 22(12): 2603-2612, 10


25. 60093 HIV-LS-367; WOS-HIV-2/4/2007

Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions

Matskevich, AA, Ziogas, A, Heinrich, J, Quast, SA, and Moelling, K

AIDS RESEARCH AND HUMAN RETROVIRUSES 2006. 22(12): 1220-1230, 11


26. 60094 HIV-LS-367; WOS-HIV-2/4/2007

Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals

Bessong, PO, Mphahlele, J, Choge, IA, Obi, LC, Morris, L, Hammarskjold, ML, and Rekosh, DM



27. 60095 HIV-LS-367; WOS-HIV-2/4/2007

Structural studies of algal lectins with anti-HIV activity

Ziolkowska, NE and Wlodawer, A

ACTA BIOCHIMICA POLONICA 2006. 53(4): 617-626, 10


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024